Research ArticleClinical Investigations
Quantification of Dynamic 11C-Phenytoin PET Studies
Syahir Mansor, Ronald Boellaard, Femke E. Froklage, Esther D.M. Bakker, Maqsood Yaqub, Rob A. Voskuyl, Lothar A. Schwarte, Joost Verbeek, Albert D. Windhorst and Adriaan Lammertsma
Journal of Nuclear Medicine September 2015, 56 (9) 1372-1377; DOI: https://doi.org/10.2967/jnumed.115.158055
Syahir Mansor
1Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
Ronald Boellaard
1Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
Femke E. Froklage
2Department of Neurology, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands; and
Esther D.M. Bakker
1Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
Maqsood Yaqub
1Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
Rob A. Voskuyl
2Department of Neurology, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands; and
Lothar A. Schwarte
3Department of Anaesthesiology, VU University Medical Center, Amsterdam, The Netherlands
Joost Verbeek
1Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
Albert D. Windhorst
1Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
Adriaan Lammertsma
1Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 56, Issue 9
September 1, 2015
Quantification of Dynamic 11C-Phenytoin PET Studies
Syahir Mansor, Ronald Boellaard, Femke E. Froklage, Esther D.M. Bakker, Maqsood Yaqub, Rob A. Voskuyl, Lothar A. Schwarte, Joost Verbeek, Albert D. Windhorst, Adriaan Lammertsma
Journal of Nuclear Medicine Sep 2015, 56 (9) 1372-1377; DOI: 10.2967/jnumed.115.158055
Quantification of Dynamic 11C-Phenytoin PET Studies
Syahir Mansor, Ronald Boellaard, Femke E. Froklage, Esther D.M. Bakker, Maqsood Yaqub, Rob A. Voskuyl, Lothar A. Schwarte, Joost Verbeek, Albert D. Windhorst, Adriaan Lammertsma
Journal of Nuclear Medicine Sep 2015, 56 (9) 1372-1377; DOI: 10.2967/jnumed.115.158055
Jump to section
Related Articles
Cited By...
- Imaging the Activity of Efflux Transporters at the Blood-Brain Barrier in Neurologic Diseases: Radiotracer Selection Criteria
- Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate 11C-Metoclopramide Assessed with PET Imaging in Humans
- Parametric Methods for Dynamic 11C-Phenytoin PET Studies
- Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein
- Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide